Cd80-flox 基因敲除小鼠

1. Shahbandi, Ashkan, Chiu, Fang-Yen, Ungerleider, Nathan A, Rao, Sonia G, Jackson, James G. 2022. Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80. In Nature cancer, 3, 1513-1533. doi:10.1038/s43018-022-00466-y. https://pubmed.ncbi.nlm.nih.gov/36482233/

2. Watanabe, Ayano, Inoue, Naoya, Watanabe, Mikio, Hidaka, Yoh, Iwatani, Yoshinori. 2019. Increases of CD80 and CD86 Expression on Peripheral Blood Cells and their Gene Polymorphisms in Autoimmune Thyroid Disease. In Immunological investigations, 49, 191-203. doi:10.1080/08820139.2019.1688343. https://pubmed.ncbi.nlm.nih.gov/31755324/

3. Jaggi, Ujjaldeep, Matundan, Harry H, Oh, Jay J, Ghiasi, Homayon. 2024. Absence of CD80 reduces HSV-1 replication in the eye and delays reactivation but not latency levels. In Journal of virology, 98, e0201023. doi:10.1128/jvi.02010-23. https://pubmed.ncbi.nlm.nih.gov/38376148/